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A B S T R A C T
Mycobacterium bovis (M. bovis) is the causative agent of bovine tuberculosis, a chronic infectious disease that can
aﬀect cattle, other domesticated species, wild animals and humans. This disease produces important economic
losses worldwide. Two M. bovis strains (04-303 and 534) have been isolated in Argentina. Whereas the 04-303
strain was isolated from a wild boar, the 534 strain was obtained from cattle. In a previous study, six weeks after
infection, the 04-303 strain induced 100% mortality in mice. By contrast, mice infected with the 534 strain
survived, with limited tissue damage, after four months. In this study we compared all predictive proteins
encoded in both M. bovis genomes. The comparative analysis revealed 141 polymorphic proteins between both
strains. From these proteins, nine virulence proteins showed polymorphisms in 04-303, whereas ﬁve did it in the
534 strain. Remarkably, both strains contained a high level of polymorphism in proteins related to phthiocerol
dimycocerosate (PDIM) synthesis or transport. Further experimental evidence indicated that only mutations in
the 534 strain have an impact on PDIM synthesis. The observed reduction in PDIM content in the 534 strain,
together with its low capacity to induce phagosome arrest, may be associated with the reported deﬁciency of this
strain to replicate and survive inside bovine macrophages. The ﬁndings of this study could contribute to a better
understanding of pathogenicity and virulence aspects of M. bovis, which is essential for further studies aiming at
developing new vaccines and diagnostic techniques for bovines.
1. Introduction
Mycobacterium bovis is the causative agent of bovine tuberculosis, a
chronic infectious disease disseminated worldwide that mainly aﬀects
cattle, although it can also aﬀect other domesticated species, wild an-
imals and humans (Wobeser, 2009; Michel et al., 2003). M. bovis
belongs to the Mycobacterium tuberculosis complex (MTBC), which tra-
ditionally consists of M. tuberculosis (the main agent of human tu-
berculosis), M. africanum, M. microti, M. canettii, M. bovis, M.caprae, M.
pinnipedii and the recently incorporated species M. suricattae, M. mungi
and M. orygis (Alexander et al., 2010; van Ingen et al., 2012). These
species are genetically very similar, and share a conserved synteny as
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well as 99.9% of the genome (Brosch et al., 2002).
Brosch et al. (Brosch et al., 2002) demonstrated that MTBC mem-
bers have evolved from a common ancestor via successive DNA dele-
tions, thus resulting in the present Mycobacterium speciation and in
their diﬀerences in pathogenicity. Despite their high overall genetic
relationship, MTBC species exhibit a wide range of phenotypes and host
ranges. The deletion of genetic information, together with the presence
of single nucleotide polymorphisms (SNP) across chromosomes of
MTBC species, probably explains the diﬀerent host ranges, virulence
and immunopathology found among these species.
Garnier et al. (Garnier et al., 2003) published the complete genome
sequence ofM. bovis in June 2003, ﬁve years after the publication of the
M. tuberculosis genome sequence (Cole et al., 1998). The genome of M.
bovis andM. tuberculosis are more than 99.95% identical, but with seven
deleted regions ranging from 1 kilobase (kb) to 12.7 kb. Thus, these
gene deletions could account for the main evolutionary forces that have
shaped the M. bovis genome. Indeed, many of the absent or altered
genes in M. bovis are also missing or altered in M. leprae, an obligate
intracellular pathogen that has undergone a signiﬁcant reduction in its
genome (Garnier et al., 2003).
A deeper knowledge of the mycobacterial virulence factors is es-
sential for the development of new vaccines and drugs to help manage
the disease and move towards a world free of tuberculosis.
The M. bovis 04-303 strain was isolated from a wild boar in the La
Pampa province of Argentina in 2004, and characterized as spoligotype
SB0140, with a Mycobacterial Interspersed Repetitive Units (MIRU)
pattern of 232224263322 (Aguilar León et al., 2009; Nishibe et al.,
2013). The M. bovis 534 strain, on the other hand was isolated from
cattle in the Santa Fe province of Argentina, in 1997. This strain was
characterized as spoligotype SB0140, with an MIRU pattern of
232224163322 (Aguilar León et al., 2009). In an experimental BALBc
model of progressive pulmonary tuberculosis, mice infected with the
04-303 strain exhibited high mortality (Aguilar León et al., 2009). The
animals developed a mild inﬂammatory response, followed by sudden
pneumonia, with extensive necrosis. Conversely, mice infected with the
534 strain exhibited higher survival rates and limited tissue damage,
with progressive expression of IFN-γ and elevated expression of IL-4,
TNF-α and iNOS. The 04-303 strain induced a signiﬁcantly lower ex-
pression of these immune mediators. In another study where the re-
searchers assessed the secretion of virulence factors as well as phago-
cytosis of both strains by J774A.1 macrophages, the 04-303 strain
secreted more ESAT-6 and CFP-10 than the genetically related strain
444, and was more phagocytized than BCG and even more than 444
strain (Vargas-Romero et al., 2016). In experimentally infected cattle,
the 04-303 strain produced more severe lesions, in the evaluated or-
gans, with granuloma and pneumonic areas, than the M. bovis strain,
NCTC 10772 (Meikle et al., 2011). In a guinea pig model of M. bovis
infection, the 04-303 strain was signiﬁcantly more virulent than the
NCTC 10772 strain (Meikle et al., 2011). Based on these results, the
researchers characterized M. bovis 04-303 as a highly virulent strain.
Considering the extreme pathogenic phenotype of the 04-303 strain
and the attenuated phenotype of the 534 strain, we hypothesized that
the diﬀerences in virulence could be attributable to nonsynonymous
mutations in the coding sequences. With this in mind, we performed a
comparative genomic analysis to identify nonsynonymous single nu-
cleotide polymorphisms (NS-SNP) and insertions/deletions in the
coding sequences of the M. bovis 04-303 and 534 strains. We used the
complete genome of M. bovis AF2122/97 (Garnier et al., 2003) as re-
ference.
2. Material and methods
2.1. Bacterial strains and culture media
M. bovis strains were grown in Middlebrook 7H9 medium (Difco
Laboratories, 271310) supplemented with albumin (A) 0.5%, dextrose
(D) 0.4%, and pyruvate (P) 0.5% (M7H9-AD-P) or Middlebrook 7H10
(Difco Laboratories, 262,710) supplemented with AD-P. When neces-
sary, 50 μg/ml hygromycin, μg/ml 20 kanamycin or Tween 80 (T80)
0.05% was added to the media.
The M. bovis 04-303 and M. bovis 534 strains were isolated from a
wild boar in a free-ranging ﬁeld and from dairy cattle in the humid
Pampas region, respectively, both in Argentina. The DNA from the
isolates were extracted and puriﬁed as described by van Soolingen et al.
(van Soolingen et al., 1991).
2.2. Genome sequencing and annotation
M. bovis 04-303 (Nishibe et al., 2013) and M. bovis 534 were de-
posited in the
DDBJ/EMBL/GenBank under the accession numbers GenBank:
AVSW01000000 and JQEM00000000, respectively. The genome as-
sembly showed 169 (average coverage of 27.3 x) and 72 contigs
(average coverage of 50.5 x) for the 04-303 and 534 strains, respec-
tively. Whole genome sequencing of 04-303 and 534 strains was per-
formed on starter cultures from frozen seed stocks (Dr Zumárraga,
personal communication).
The quality of the genome assemblies was assessed following the
CheckM automated method (Parks et al., 2015). This method provides a
broader set of marker genes that are speciﬁc to the position of a genome
within a reference genome tree, as well as information about the col-
location of these genes. According to the CheckM default thresholds,
both assemblies exhibited a satisfactory quality. The coding densities of
both genomes were within the expected range for bacterial genomes.
2.3. Single nucleotide polymorphisms
The open reading frames and protein sequences of the reference
strain, AF2122/97 (LT708304.1), were compared with the whole
genome of both strains. NS-SNPs were found using an in-house script
written in Python and Translated BLAST: tblastn.
The algorithm tbBLASTn was used to retrieve NS-SNPs in the M.
bovis genomes deposited in NCBI. The Query was a multifasta of the 30
selected sequences (S1) and subject was Mycobacterium bovis (taxid
1765), excluding M. bovis BCG (taxid 33892). The expected threshold
was set up to 1e-6.
2.4. Virulence-related genes analysed
This analysis was performed with all genes from both genomes, as
published by Forrellad et al. (Forrellad et al., 2013) and Sassetti et al.
(Sassetti et al., 2003) and/or with genes listed in the TubercuList da-
tabase server (http://genolist.pasteur.fr/TubercuList). The analysis of
conserved domains was done with ScanProsite (http://prosite.expasy.
org/scanprosite/.) and CD search (https://www.ncbi.nlm.nih.gov/
Structure/bwrpsb/bwrpsb.cgi).
2.5. Analysis of protein stability changes due to NS-mutations
The STRUM method was used for predicting the fold stability
change (ΔΔG) of virulence factors upon single-point NS-SNP mutations
(http://zhanglab.ccmb.med.umich.edu/STRUM/).
2.6. Lipid analyses
Total lipids from bacterial cells were extracted following procedures
described previously (Stadthagen et al., 2005). Brieﬂy, cultures were
grown to late exponential phase (optical density (OD) 600 nm 0.8–1)
and total cell wall lipids extracted with chloroform:methanol. Fatty acid
and mycolic acid methyl esters (FAMES and MAMEs, respectively) were
derived from extractable lipids as described by Stadthagen et al.
(Stadthagen et al., 2005). Lipids were analysed by TLC on silica gel
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60F254 by loading the same lipid quantities per lane (100 μg). TLCs
were developed in three diﬀerent solvent systems and revealed by
spraying with a CuSO4-phosphoric acid solution and heating. These
experiments were repeated with ﬁve independent lipid samples of each
M. bovis strain.
2.7. Liquid chromatography-mass spectrometry (LC–MS) analysis
Total lipids were analysed by LC/MS as described by Sartain et al.
(Sartain et al., 2011). High-resolution Agilent 6220 TOF and Brucker
micrOTOF-Q II mass spectrometers interfaced to a LC were used for the
analysis. Data ﬁles were analysed with Agilent’s Mass hunter work-
station software (Version B.02.00, build 2.0.197.0) and software
MZmine2 (Pluskal et al., 2010) to identify compounds using ‘molecular
feature extractor’.
The Agilent mass proﬁler program was used to compare all the li-
pids present in the samples. Most compounds were identiﬁed using the
lipid database developed by Sartain et al. Compounds of interest were
semi-quantiﬁed by comparing their relative abundance in the samples.
2.8. Peripheral blood mononuclear cell (PBMC) isolation and monocyte-
derived macrophages (BMDM) diﬀerentiation
Peripheral blood samples were obtained from cattle selected from
the experimental herd of INTA. All these animals tested negative for
bovine tuberculosis infection according to the single intradermal tu-
berculin test and Interferon-γ release test. A sample of blood (50mL)
was taken from each animal in sterile conditions and PBMCs were se-
parated from heparinized blood by centrifugation over histopaque 1077
following the manufacturer’s protocol. Monocytes were diﬀerentiated
by culturing PBMCs on 24-well plates with coverslips (or not) con-
taining RPMI 1640 complete medium supplemented with 10% of au-
tologous plasma at 37 °C and 5% CO2. Adherent cells were maintained
in culture for 5 days to obtain BMDMs. The cell viability was conﬁrmed
by trypan blue exclusion assay (data not shown). Sample collection and
animal handling were done in compliance with the regulations of the
Ethical Committee of INTA (CICUAE).
2.9. BMDM infections
M. bovis strains were cultured to exponential growth phase (OD
600 nm 0.4-0.6), harvested, washed and resuspended in RPMI medium.
The bacterial suspensions were centrifuged at 900 g for 10min to
eliminate bacterial clumps in the pellets. The optical densities of the
bacterial suspensions were adjusted to a multiplicity of infection (MOI)
of 2. BMDMs were infected for 2 h at 37 °C and 5% CO2 (uptake) and
then washed three times to eliminate extracellular bacteria.
Subsequently, BMDMs were incubated in RPMI medium supplemented
with 10% of autologous plasma for 3, 24, 48 and 72 h accordingly to the
assay. Three and seven independent infections were performed for in-
tracellular traﬃcking and for bacterial persistence assays, respectively.
Indirect immunoﬂuorescence and confocal microscopy
Bovine BMDMs (4× 105) were seeded in 24 well-plate with slides
and then infected with the M. bovis strains at a MOI of 2, as described
before. After 72 h of infection, cells were ﬁxed with 4% paraf-
ormaldehyde solution in PBS (PFA) for 30min and quenched by in-
cubation with 50mM glycine solution for 30min. The cells were then
permeabilized with 0.05% saponin in PBS containing 1% bovine serum
albumin (BSA) for 15min, followed by overnight incubation with rabbit
anti-Mycobacterium primary antibody (Origene, USA) diluted 1:50 in
PBS. Next, a secondary antibody anti-Rabbit conjugated to FITC
(Jackson Immuno Research Labs, Inc.) diluted 1:600 in PBS was added
and incubated for 1 h. Subsequently, the cells were incubated with goat
anti-LAMP-3 (Santa Cruz Biotechnology, Santa Cruz, CA) primary an-
tibody diluted 1:50 in PBS for 2 h. Secondary anti-goat antibody con-
jugated to cy3 (Jackson Immuno Research Labs, Inc.) was used diluted
1:600 in PBS. The cells were mounted with mounting medium (Dako,
Denmark) and analysed by confocal microscopy using an SP5 AOBS
confocal microscope (Leica Microsystems, Germany) at the Laboratorio
Integral de Microscopía, CICVyA, INTA. Mycobacterial internalization
was monitored using the ﬂuorescence of FITC (green). LAMP-3 asso-
ciation with mycobacterial phagosomes was analysed in at least 500
cells using Fiji software (U.S. National Institutes of Health, Bethesda,
MD) as described previously (Vázquez et al., 2017). The experiments
were performed in duplicates in three independent experiments. The
statistical analysis was performed using two-tailed Student’s t-test.
2.10. Recombinant M. bovis strains
The esat-6 gene was PCR ampliﬁed from genomic DNA of the 04-303
and 534 strains with speciﬁc primers, and cloned in NdeI and HindIII
sites of pVV16 vector, which is a derivative of pMV261 (Stover et al.,
1991) that allows His-tag fusion for expression in M. smegmatis. The
inserts in the recombinant plasmids were sequenced; the results showed
that the polymorphism of esat-6 of 04-303 and 534 deposited in the
DDBJ/EMBL/GenBank were maintained in the recombinant plasmids.
The recombinant plasmids PVV16-ESAT6 04-303 and PVV16-ESAT6
534 were used to transform the 534 strain. The recombinant 534 strains
were selected in 7H10-AD-P medium containing 50 μg/ml of hygro-
mycin.
2.11. Western blot analysis
After three weeks of incubation, bacterial cells were harvested by
centrifugation, broken by disruption with glass beads in a homogenizer,
and resuspended in PBS 1X for protein quantiﬁcation. Secreted proteins
were obtained from culture supernatants of bacteria grown in medium
with 0.4% glucose but without albumin. The supernatants containing
secreted proteins were precipitated with 10% trichloroacetic acid
overnight and centrifuged at 7000 g for 30min at 4 °C. The proteins
were neutralized with Tris 1M and resuspended in loading buﬀer.
The samples were subjected to electrophoresis in 12–15 % SDS-
PAGE gels, subsequently transferred to nitrocellulose membranes and
stained with Rouge Ponceau solution. The membranes were blocked
with TBS (10mM tris−HCl pH 7.5, 150mM NaCl) supplemented with
5% skim milk for 30min before performing an overnight incubation
with primary antibodies (monoclonal anti-ESAT-6 (1/100) or poly-
clonal GroEL (1/5000). The nitrocellulose membranes were then in-
cubated with a secondary antibody alkaline phosphatase-conjugated at
a 1:10.000 dilution for 2 h. Western blots were revealed by incubation
with BCIP/NTP solution.
3. Results and discussion
3.1. Comparative analysis of predicted proteins in M. bovis strains
The comparison of SNPs of the 04-303 and 534 strains, through the
evaluation of their genomes in relation to that of the M. bovis AF2122/
97 reference strain, retrieved 193 genes with at least NS-SNP in one of
the strains or in both (Supplementary material 1). In total, 57 genes
carried NS-SNPs in 04-303, whereas 84 did it in 534. Interestingly, 53 of
the NS-SNPs were common to both strains. From the exclusive NS-
mutations, nine produced a frameshift, whereas two resulted in pre-
mature stops in the proteins (Supplementary material 1).
A functional categorization (tuberculist.epﬂ.ch) of the polymorphic
proteins between 04-303 and 534 showed that the most represented
categories in mutant proteins of 534 are PE/PPE and intermediary me-
tabolism and respiration. On the other hand, 04-303 carries NS-SNPs
mainly in genes of the lipid metabolism category (Supplementary ma-
terial 1).
M. Bigi, et al. Veterinary Microbiology 239 (2019) 108482
3
3.2. Polymorphic virulence genes
A search for virulence genes in the polymorphic gene dataset, based
on the bibliography and on the Tuberculist functional categories, gave
nine virulence genes with nonsynonymous polymorphisms in 04-303
and ﬁve in 534. These 14 polymorphic genes with a putative or de-
monstrated role in mycobacteria virulence grouped in ﬁve functional
categories: three genes are involved in cell wall process (esxA, pstS3 and
irtAB); eight are associated with lipid metabolism (pks12, mmpL3,
pks10, mmpL7, mmpL8, Mb3114, ppsA and ppsE); one was involved in
intermediary metabolism and respiration (htrA); one encoded a reg-
ulatory protein (hrcA) and one categorized as virulence gene (hpX)
(Fig. 1). These results highlight the relevance of the cell wall and re-
lated lipids in the mechanism of virulence of pathogenic mycobacteria.
Of the eight virulence polymorphic proteins involved in lipid me-
tabolism, four are enzymes of phthioceroldimycocerosate (PDIM)
synthesis/transport pathways, three are MmpL proteins involved in
lipid transport and one is a putative glycerolphosphodiesterase
(Mb3114) predicted to be required for in vivo survival ofM. tuberculosis
(Sassetti et al., 2003). The genes mmpL3, 7 and 8 have NS-SNPs in the
04-303 strain. The proteins of the MmpL family translocate complex
lipids across the cell envelope of mycobacteria. MmpL8 transfers the
sulfolipid SL-1 to the cell envelope (Converse et al., 2003) and MmpL7
transports PDIM. A study demonstrated that the lack of MmpL7 in M.
tuberculosis severely aﬀects the virulence of the bacteria, whereas the
absence of MmpL8 attenuates it (Domenech et al., 2005). MmpL 7 and 8
of 04-303 showed aa changes that predictably favours its stability
(Table 1). Therefore, if mutations in MmpL proteins have an impact on
the virulence of 04-303, they should favour the protein functionality.
MmpL3 (Mb0212) transports trehalose momomycolate, a precursor of
the mycobacterial outer membrane component trehalose dimycolate as
well as mycolic acids bound to arabinogalactan. However, since this
gene is essential for bacterium replication in vitro, it is diﬃcult to
speculate about the role of the mmpL3 mutation in the virulence phe-
notype of 04-303. In addition, the mutation seems to not aﬀect the lipid
transportation function, since we did not detect substantial diﬀerences
in the content of TDM or extractable mycolic acids between strains
(Supplementary material 2A and 2B).
The PDIM lipids consist of a long-chain β-diol - phthiocerol - es-
teriﬁed by one type of such long-chain multiple methyl-branched fatty
Fig. 1. Venn diagram illustrating polymorphic virulence genes of both 04-303 and 534 strains grouped as functional categories.
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acids called mycocerosic acids. PDIMs constitute major virulence fac-
tors of M. tuberculosis, particularly, during the early step of infection
when bacilli encounter their host macrophages. Two transcriptional
units are involved in the synthesis and transport of PDIMs. These
transcriptional units contain many genes involved in fatty acid synth-
esis/modiﬁcation, many of them with homology to fatty acyl CoA
synthases and dehydrogenases, as well as a set of genes with homology
to polyketide synthases (Pks). Pks are multifunctional enzymes that,
along with adjacent or neighbouring Acyl-CoA synthases and dehy-
drogenases could be involved in the synthesis of complex lipids such as
mycocerosic acid, sulfolipids, diacyltrehalose/polyacyltrehalose (DAT/
PAT). Mutants in pks12 and pks10 genes of M. tuberculosis displayed
defect in PDIM production (Sirakova et al., 2003). However, later stu-
dies demonstrated that Pks12 is involved in the synthesis of Mannosyl-
beta -1-phosphomycoketides (MPM) (Angala et al., 2014). Therefore, at
least for Pks12, the role of this enzyme in the accumulation of PDIM
seems to be secondary or indirect.
Pk10 showed polymorphisms only in the 534 strain, whereas Pks12
was polymorphic in both strains. A single nucleotide deletion in the
coding sequence of Pks12 produced a frameshift in the resulting protein
of the 04-303 strain, whereas a double amino-acid (aa) substitution
occurred at the C terminal end (QxH and ExH) of Pks12 in 534.
Moreover, PpsA and PpsE, which are also polyketide synthases encoded
in one of the PDIM loci (Domenech and Reed, 2009), showed NS-mu-
tations in the 534 strain. Although predictive analysis indicates that
these mutations are supposed to produce stability to the resulting
protein structures (Table 1), they map in conserved domains, according
to ScanProsite (data not shown). Therefore, the enzymatic activities of
PpsA and PpsE may be aﬀected.
Altogether, this genomic analysis shows a remarkable high level of
polymorphism in proteins related to PDIM synthesis or transport in both
strains.
The comparative genomic analysis identiﬁed only one NS-mutation
in a regulatory gene of 04-303 and none in 534. The identiﬁed poly-
morphic regulatory gene is hrcA (Mb1255). HrcA is a heat-shock protein
that acts as a transcriptional repressor for members involved in the
Hsp60 (GroEL) response to M. tuberculosis (Stewart et al., 2002). The
mutation of HrcA in 04-303 produced an aa change from aspartate, a
negatively polar side-chain aa, to asparagine, an uncharged polar side
chain aa. This aa change should destabilize the protein structure as
predicted by STRUM (Table 1). A western blot analysis showed no
diﬀerences in the expression of the GroEL protein (Supplementary
material 2D), suggesting no alteration in the expression level because of
this aa change in HrcA.
In this study, we detected NS-mutations in four membrane/cell wall
associated genes: irtA, pstS3, hpX and htrA. IrtA together with IrtB are
proteins involved in iron acquisition. Here, we identiﬁed a change of a
leucine, an uncharged polar side chain aa, to an arginine in the protein
sequence of IrtA in the 534 strain. The mutation maps in a conserved
domain detected by ScanProsite tool (data not shown).
PstS-3 is a protein involved in the transport of inorganic phosphate
together with PhoT. Previous results indicate that PstS-3 may have a
minor role in the virulence mechanisms of M. tuberculosis (Brodin et al.,
2010). In the 04-303 strain, pstS-3 carries a NS-SNP that is predicted to
produce a negative stability change in the resulting protein (Table 1).
This suggests that the mutation does not contribute to the virulence
phenotype of the M. bovis strain.
Hpx carries a NS-mutation in the 04-303 strain. This gene encodes a
putative non-heme haloperoxidase identiﬁed in the cell membrane of
M. tuberculosis (Mawuenyega et al., 2005) that may be involved in de-
toxiﬁcation reactions. No experimental characterization has been done
so far and therefore its role in M. bovis virulence is still undeﬁned.
HtrA-1 (DegP) is a member of the serine protease family. This
protein is essential, as determined by saturation transposon mutagen-
esis and through attempts to knock-out the gene (Roberts et al., 2013)
(Sassetti et al., 2003). The essentiality of htrA-1 indicates that its NS-
mutation in the 534 strain should not aﬀect the protein functionality,
although the mutation predictively aﬀects the protein stability.
Only the 6 kDa early secretory antigenic target (ESAT-6) or EsxA,
which is a secreted virulence factor, showed polymorphism between the
strains. ESAT-6 is a highly conserved protein (Encinas et al., 2018) that
is part of a protein family known as Esx. ESAT-6 of M. bovis forms a
dimer with CFP10 (culture ﬁltrate antigen or EsxB) (Mb3904), a strong
stimulator of cell-mediated immunity (Jones et al., 2010). ESAT-
6:CFP10 can sequester the host protein beta-2-microglobulin (b2M) to
inhibit the cell surface expression of the major histocompatibility
complex (MHC)-I-b2M; which may undermine the host’s adaptive im-
mune responses, thereby leading to the establishment of a successful
infection (Sreejit et al., 2014).
Indeed, the 04-303 strain showed a NS-SNP in esat-6 that improves
the stability of the protein, as predicted by STRUM analysis (Table 1).
Furthermore, this NS-SNP does not aﬀect the secretion of the protein, as
Table 1
Polymorphic virulence proteins in M. bovis strains compared to M. bovis AF2122/97.
Mb number Name Rv number Description Length Location aa Mb aa Rv Change ddG %§
M. bovis strain 04-303
Mb0212c MmpL3 Rv0206c Transport protein Mmpl3 944 820 A A P ND 3.1
Mb0951 PstS3 Rv0928 Periplasmic phosphate-binding lipoprotein 370 84 N N S −1.37 3.1
Mb2074c Pks12 Rv2048c Polyketide synthase Pks12 4151 3971 S S Fs ND 9.4
Mb2395c HrcA Rv2374c Probable heat shock protein transcriptional repressor 343 78 D D N +1.6 3.1
Mb2967 MmpL7 Rv2942 Transport protein Mmpl7 920 407 I I T +2.5 3.1
Mb3114 Rv3087 Rv3087 Possible triacylglycerol synthase 472 453 S S L ND 3.1
Mb3196c Hpx Rv3171c Possible non-heme haloperoxidase 299 7 D D G ND 3.1
Mb3853c MmpL8 Rv3823c Transport protein Mmpl8 1089 451 L L V +4.93 3.1
Mb3905 EsxA Rv3875 6 kda early secretory antigenic target esxa (esat-6) 95 63 T T A +0.52 3.1
M. bovis strain 534
Mb1255 HtrA Rv1223 Serine protease htra (degp protein) 528 272 I I M −0.08 18.8
Mb1383 IrtA Rv1348 Atp-binding protein Abc transporter 859 562 R R L +2.35 9.4
Mb1688 Pks10 Rv1660 Chalcone synthase Polyketide synthase Pks10 353 330 S S G ND 2.6
Mb2074c Pks12 Rv2048c Polyketide synthase Pks12 4151 3982 H Q Q ND 6.3
Mb2074c Pks12 Rv2048c Polyketide synthase Pks12 4151 3985 H E E ND 3.1
Mb2956 PpsA Rv2931 Polyketide synthase PpsA 1876 1809 F F L +0.17 15.6
Mb2960 PpsE Rv2935 Polyketide synthase PpsE 1488 538 G G S +4.92 18.8
§ frequency of NS-mutation in M. bovis isolates.
aa Mb Amino acid in M. bovis AF2122/97 strain.
aa Rv Amino acid in M. tuberculosis H37Rv strain.
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evidenced by the equivalent amounts of ESAT-6 expression in the cul-
ture supernatants of both strains (Supplementary material 2D).
3.3. Polymorphism in conserved protein domains
Five polymorphisms map in conserved predicted domains (Fig. 2).
The 04-303 strain has a polymorphism in the major facilitator super-
family (MFS) and glycerophosphodiester phosphodiesterase (GP-PDE)
domain of Mb0805c and Mb2300c, respectively. Mb0805c is a putative
multidrug resistance integral membrane eﬄux protein (Emrb), whereas
Mb2300c is a putative glycerolphosphodiesterase. For both proteins,
the predictive domains encompass more than 89% of the full protein
length (Fig. 2A) and, therefore, it is diﬃcult to assign an impact for the
aa changes.
In the 534 strain, Mb1496c and Mb3267c are conserved hypothe-
tical protein with an aa change in an intein N-terminal splicing and a
patatin-like phospholipase (PNPLA) domains, respectively (Fig. 2B). In
addition, Mb2274c is a putative transcriptional regulatory protein that
carries a predictive aa change in a TetR-type HTH domain. All of these
conserved domains that showed polymorphisms in the 534 strain in
relation to the M. bovis reference strain are in proteins with no estab-
lished functions in mycobacteria. However, Mb2274c has been assigned
a predictive transcriptional regulation function (http://genolist.
pasteur.fr/BoviList/). Thus, the mutation in its HTH domain may
have an impact on the binding of the protein to the DNA, which in turn
would aﬀect the transcriptional expression of the target genes.
3.4. Frameshift mutations
Rv1264 (Mb1295) is one of the 15 adenylyl cyclases of M. tu-
berculosis that produce cAMP (Findeisen et al., 2007). This enzyme is
activated at acidic pH due to pH-dependent structural transitions of the
Fig. 2. Schematic representation of polymorphisms in protein conserved domains of (A) 04-303 and (B) 534 strains. Only domains identiﬁed by both ScanProsite and
CD search were considered in this study.
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Rv1264 dimer. In the 534 strain, a frameshift mutation in Mb1295
produced a predictive larger protein than that of the wild type (410 vs
397 aa). However, the mutated region is located at the end of the
carboxyl terminal domain of the protein and does not encompass con-
served domains or a conserved aa.
A single nucleotide deletion in Mb2813 of 534 results in a pre-
dictable protein of only 17 aa.Mb2813 encodes a putative lipid-transfer
protein Ltp1 (Table 2). The role of this protein during tuberculosis in-
fection remains unknown. Based on the relevance of the mycobacterial
lipids for the interaction with their host, it is tempting to speculate that
the lack of this putative lipid transfer protein may impact on the
virulence of the strain 534.
Other frameshift mutations in the 534 strain are those located in
Mb2437c and Mb3370, which produced truncated proteins of 133 and
150 aa, respectively (Table 2). These aberrant proteins would conserve
only 56 and 83 aa of the amino terminal portion of the wild type
proteins, respectively. These genes encode hypothetical proteins not
previously described in the literature.
PE family protein PE14 (Mb1246c) of 534 carries a ﬁve nucleotides
insertion that results in a shorter protein of 69 aa in relation to the
reference strain. Although the function of this protein is still unknown,
this ﬁve nucleotides insertion is also present in M. tuberculosis H37Rv
reference strain but in diﬀerent position. The insertion localizes at
nucleotide position 205 from 5′ end ofMb1246c and nucleotide position
204 from 5′ end of Rv1214c.
A mutation that maps at the end of Mb3610 in the 534 strain pro-
duces a predictable protein 81 aa shorter than that of the wild type
(Table 2). Mb3610, a putative tRNA/rRNAmethyltransferase, seems to
be essential for M. tuberculosis growth and, thus, any mutation detected
in this gene should have no impact on the functionality of the protein.
Only two frameshift mutations were exclusively identiﬁed in the 04-
303 strain (Table 2). One is in the pks12 gene, previously mentioned,
and the other maps in the Mb3920c gene. Mb3920c (EsxD) is a member
of the ESAT-6 family that, together with Mb3919c (EsxC), may be se-
creted by the ESX-2 system (Knudsen et al., 2014). Nevertheless, EsxD
and EsxC lack the ESX signature tag. None of these proteins have been
identiﬁed in the culture supernatants. The deletion of a single nucleo-
tide from Mb3902c in the 04-303 strain would produce a protein of 63
aa, of which only the ﬁrst 40 are identical to the wild type protein. The
dimmer EsxC/EsxD formulated in adjuvant CAF01 has shown to confer
a signiﬁcant level of protection againstM. tuberculosis in a mouse model
(Knudsen et al., 2014). This ﬁnding may suggest that the lack of a full-
length EsxD would facilitate 04-303 to evade the host immune re-
sponse.
3.5. Polymorphisms in other M. bovis isolates
We extended the analysis of the selected polymorphic proteins to
other 30 M. bovis genomes obtained from the public database (https://
www.ncbi.nlm.nih.gov/gquery/). In the 04-303 strain, most of the NS-
mutations in the selected genes are unique. The exceptions are in the
case of pks12 (Table 1), which encodes a protein highly polymorphic
among M. bovis strains, and Mb2300c (Rv2300c) which showed the
same polymorphism in 96.9% of the analysed M. bovis isolates (data not
shown) This unexpected ﬁnding may explain the exacerbated virulence
of 04-303 (Meikle et al., 2011).
The frequency of mutations is contrasting in the 534 strain, where
most of NS-SNPs are present in other M. bovis isolates. Based on the
premise that evolutionary forces would not select mutations that have a
negative impact on the virulence of M. bovis, we should conclude that
most of the mutations in the 534 strain are not associated with its at-
tenuation. The exceptions are pks10, the adenylyl cyclases Mb1295
(Rv1264) and Mb1496 (Rv1461) (Table 1 and data not shown), which
have unique mutations. In addition, for hrtA, only another strain shares
this NS-mutation with M. bovis 534. In the case of these genes, the
mutations would be eﬀectively associated with a disadvantage for in-
fection.
3.6. Comparative lipid analysis
Based on the high number of lipid-related proteins with poly-
morphisms between strains, we decided to compare the lipid content of
these bacteria. Preparation and TLC analysis of total lipids from the
cellular extractable lipids showed that some lipids were exclusively
present in the 04-303 strain (Fig. 3A). When total lipids prepared from
cell extracts were solved in a solvent system that resolved PDIM, we
detected the accumulation of multiple bands in 04-303, which were
absent from the 534 strain (Fig. 3B). To determine whether these dif-
ferences in PDIM proﬁles between strains were a consequence of bac-
terial sub-culturing, we analysed the PDIM content of bacterial cells
obtained from seed stocks (original cultures with minimal passages).
The lipid proﬁles were similar to those of Fig. 3B (Supplementary
material 2C). This result indicates that the lower content of PDIM in the
534 strain was not due to the mutations in PDIM-related genes accu-
mulated during in vitro bacterial culturing. These phenotypes, which
were reproducible throughout ﬁve independent experiments, suggest
that the NS-mutations either in pk10, ppsA, ppsE or altogether drama-
tically impact on the PDIM production of 534.
In addition, the diﬀerences in lipid content were conﬁrmed by an
LC–MS analysis of the cellular extractable lipids from both strains
(Fig. 3C, D and E). Mass spectra clearly showed an increase in the peaks
eluting between 22.5 and 26.5 min that matched with mycoside B, a
lipid that shares much of the biosynthetic pathways of PDIM, PDIMA
and PDIMB in samples from the 04-303 strain. The higher accumulation
of PDIMs in the 04-303 strain than in the 534 strain was conﬁrmed in a
second LC-MS analysis with a set of lipid samples obtained from seed
stocks (data not shown). Altogether, the production of PDIMs showed to
be altered in 534 strain.
Table 2
Frameshift mutations in M. bovis strains compared to M. bovis AF2122/97.
Mb number Name Rv number Description Length Location of Fs
04-303
Mb3920c EsxD Rv3891c Esat-6 like protein esxd 107 40
534
Mb1246c PE14 Rv1214c Pe family protein 376 69*
Mb1295 – Rv1264 Adenylyl cyclase 397 371
Mb2437c – Rv2414c Conserved hypothetical protein 523 58
Mb2813c Ltp1 Rv2790c Probable lipid 401 6
Mb3370 – Rv3338 conserved hypothetical protein 297 83
Mb3610c – Rv3579c Possible trna/rrna methyltransferase 403 317
§frequency of NS-mutation in M. bovis isolates.
*insertion of 5′ACAAG.3′
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3.7. Intracellular traﬃcking of M. bovis strains
ESAT-6 in concert with other proteins and PDIM lipids contribute to
the phagosomal escape of M. tuberculosis (Augenstreich et al., 2017).
Thus, the variable abundance of PDIM between the 04-303 and 534
strains and the polymorphism in ESAT-6 may have an impact on in-
tracellular localization of both strains. To address this point, we eval-
uated the maturation stage of mycobacterial phagosomes by using im-
munoﬂuorescence and confocal microscopy.
M. bovis strains were used to infect bovine macrophages for 2 h of
uptake and 72 h of chase, as described in Materials and Methods.
Consistent with our presumption, the LAMP-3 (the late endocytic
marker lysosomal-associated membrane protein 3) association with the
04-303 was signiﬁcantly lower than with the 534 strain (Fig. 4B). These
results indicate that the 534 strain has a reduced ability to avoid an-
timicrobial mechanisms of macrophages and therefore it cannot persist
inside bovine macrophages. As expected, the number of CFU in mac-
rophages infected with strain 04-303 was signiﬁcantly higher than that
of macrophages infected with either strain 534 or BCG at 72 h of in-
fection (Fig. 4A). These results are in line with our previous ﬁndings
(Blanco et al., 2009).
To evaluate the impact of ESAT-6 polymorphism on the intracellular
persistence of M. bovis, we overexpressed the mutant (ESAT-6- 04-303)
and wild type (ESAT-6-534) variants of ESAT-6 in the 534 strain from
plasmid pVV16. The introduction of the mutant allele of esat-6 in 534
did not aﬀect the intracellular localization of the strain in late endo-
somes (Supplementary material 2E-i). This result suggests that the
mutation of ESAT-6 does not improve the phagosomal escape of pa-
thogenic mycobacteria. In addition, we detected equivalent in-
tracellular persistence of both recombinant 534 strains at 48 and 72 h
post infection of bovine macrophages (Supplementary material 2E-ii).
Altogether these results indicate that, at least with the ex vivo model
here evaluated, the mutation in ESAT-6 does not seem to contribute to
exacerbate the virulence phenotype of strain 04-303.
4. Conclusions
In this study, we used a genomic approach to predict the molecular
bases that can explain the extreme opposite phenotypes in terms of
virulence of two genetically close M. bovis strains. Most of the NS-mu-
tations in virulence factors mapped in proteins related to transport or
metabolism of lipids. This ﬁnding reinforces the role of these
Fig. 3. Lipidomic analysis. (A, B) Thin layer chromatography analysis of total lipid from M. bovis strains. Total lipids were extracted from M. bovis strains developed
by TLC in the solvent systems (A) chloroform methanol water (90:10:1) (B) petroleum ether/diethyl ether (98:2) and revealed with CuSO4 and heating. The arrows
indicate increased lipids in 04-303. The lipid patterns were repeated in ﬁve independent experiments. (C, D, E) LCeMS analysis of total lipids from M. bovis strains.
(C) The TIC and the selection ion chromatograms at m/z 1322.314 (M+Na+ for DIMB) and at m/z 1530.382 (M+Na+ for a DIMA based mycoside B) for total
lipid extracts from 04-303 and 534 strains. Consistent with the TLC analysis, both strains show large amounts of various forms of triglycerides (labelled on the TLC of
Fig. 3). Strain 04-303 also shows substantial amounts of various forms of both mycoside B and DIM (also labelled on the TLC of Fig. 3). The selected ion chro-
matograms show that both DIM and mycoside B are present in the 04-303 strain; integration shows the ratio at approximately 75:1 (303:534) for both lipids. DIMA
and mycoside B based on DIMB were also present in the 04-303 strain in substantial amounts (data not shown). The mass spectrum of the major DIMB is shown in (D);
the structural drawing, while correct in its molecular weight, is not necessarily accurate as to which CH2 groups are in the fatty acids and which are on the main chain
of the phthiocerol backbone. Similarly, the mass spectrum of the major mycoside B based on DIMA is shown (E) and, although the phthiocerol backbone and the acyl
groups are clearly smaller than those of the DIMs, the drawing is not necessarily accurate as to which CH2 groups are in the fatty acids and which are on the main
chain of the phthiocerol backbone.
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compounds in the virulence of pathogenic mycobacteria. While most of
the mutations in virulence proteins of 534 strain are conserved in a high
number of M. bovis isolates, mutations in virulence proteins of 04-303
are mostly unique Thus, the 04-303 protein polymorphisms may con-
tribute to the high virulence of this strain. However, experimental
evidence is necessary to conﬁrm this presumption.
Although we detected several proteins with signiﬁcant changes
between strains, such as premature stop, frameshift mutations and aa
changes in conserved domains, the high number of NS-polymorphisms
in enzymes that participate in PDIM metabolism in both strains is
remarkable. This predictive analysis was then conﬁrmed with experi-
mental results and thus we demonstrated that the 534 strain has a
dramatic defect in PDIM production. The lack of PDIM and the related
lipids in the attenuated strain 534 is consistent with the role of these
lipids in the virulence of M. tuberculosis and M. bovis.
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